98%
921
2 minutes
20
Estimation and fraud detection in the case of insurance claims play a cardinal role in the insurance sector. With accurate estimation of insurance claims, insurers can have good risk perceptions and disburse compensation within proper time, while fraud prevention helps deter massive monetary loss from fraudulent activities. Financial fraud has done significant damage to the global economy, thus threatening the stability and efficiency of capital markets. Deep learning techniques have proven highly effective in addressing these challenges to analyse complex patterns and relationships in extensive datasets. Unlike traditional statistical methods, which often struggle with the intricate nature of insurance claims data, deep learning models performs well in handling diverse variables and factors influencing claim outcomes. To this extent, it explores the deep learning models like VGG 16 & 19, ResNet 50, and a custom 12 & 15-layer Convolutional Neural Network for accurate estimation of insurance claims and detection of fraud. The proposed work enhanced with Enhanced Hippopotamus Optimization Algorithm (EHOA) combined with a custom 12-layer CNN to optimize the hyperparameters and enhance the performance of the model. Overcoming challenges such as local minima and slow convergence, dynamic population adjustment, momentum-based updates, and hybrid fine-tuning are used with the EHOA. The experimental results reveal that the newly proposed EHOA-CNN-12 attains excellent accuracy (92%) and efficiency in comparison to other state-of-the-art approaches in claims estimation and fraud detection tasks.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12297633 | PMC |
http://dx.doi.org/10.1038/s41598-025-12848-0 | DOI Listing |
Scand J Surg
September 2025
Department of Surgery, Sahlgrenska Hospital, Gothenburg, Sweden.
Background: In recent years, as new strategies have been developed, there has been a reduction of invasive interventions for prevention or treatment of ischaemic cerebral events. Furthermore, surgical treatment has been centralized to major vascular centra.
Aim: This study analyzed registered malpractice claims to the insurance during two decades.
Int Urol Nephrol
September 2025
Department of Urology, Brigham and Women's Hospital, Harvard Medical School, 45 Francis St, ASB II-3, Boston, MA, 02115, USA.
Background: With the advancement of MR-based imaging, prostate cancer ablative therapies have seen increased interest to reduce complications of prostate cancer treatment. Although less invasive, they do carry procedural risks, including rectal injury. To date, the medicolegal aspects of ablative therapy remain underexplored.
View Article and Find Full Text PDFJ Am Coll Radiol
August 2025
Vice-Chair for Clinical Research, John Westgate Hope Endowed Chair for Faculty Development, Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Assistant Professor of Radiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsyl
Objective: To determine the number of pediatric radiologists in the United States using professional imaging claims of children between 2016 and 2023 in a private payor claims database.
Methods: From 2016 to 2023, using private payer claims data (Inovalon Insights, LLC), all claim lines for radiology professional services billed by radiologists were identified. Each claim was assigned a work relative value unit (wRVU) in accordance with the CMS valuation for the claim year.
J Med Econ
September 2025
Janssen Scientific Affairs, LLC, Titusville, New Jersey.
Objectives: To provide insights into the financial burden and opportunity cost of vision loss from retinitis pigmentosa (RP) in the US by using net present value (NPV) of direct medical and nonmedical costs.
Methods: Assumptions, including economic (discount rate, median income, cost-of-living, Social Security and Medicare taxes, public insurance/supplemental benefits, nutrition assistance, and prescription drug assistance), medical (federal National Health Expenditure tables, a recent retrospective claims analysis, and Optum Health claims database) and demographic (mortality rate, increase in mortality due to visual impairment, progression of blindness, probability of survival, retirement rate, rate of disability, and RP diagnosis probability) were made to develop a NPV model. Scenario analyses were performed on benefits and costs arising from patients with RP, if vision could be preserved via novel gene therapies.
J Korean Med Sci
September 2025
Department of Preventive Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Background: Clinics and hospitals in South Korea are often perceived as competitors to each other. This study examines the overlapping roles in providing primary care provision between clinics and hospitals by analyzing the healthcare facility type where patients first receive diagnoses of hypertension (HTN) or diabetes mellitus (DM). We also explore the characteristics of patients that influence their choice of healthcare facility and compare healthcare utilization patterns in the first year post-diagnosis by facility type.
View Article and Find Full Text PDF